Solara Active Pharma Sciences Limited (BOM:890202)

Market Cap	24.92B
Revenue (ttm)	13.10B
Net Income (ttm)	-2.53B
Shares Out	n/a
EPS (ttm)	-97.95
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	470
Average Volume	405
Open	261.45
Previous Close	260.25
Day's Range	260.00 - 273.00
52-Week Range	201.25 - 560.85
Beta	n/a
RSI	54.16
Earnings Date	Apr 29, 2025

About BOM:890202

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antif...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2017
• Employees: 2,156
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 890202

Financial Performance

In 2023, BOM:890202's revenue was 12.89 billion, a decrease of -10.73% compared to the previous year's 14.44 billion. Losses were -5.67 billion, 2458.1% more than in 2022.